These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Ophthalmological involvement in Behçet disease. Apropos of 520 cases]. el Belhadji M, Hamdani M, Laouissi N, Zaghloul K, Amraoui A, Benamour S. J Fr Ophtalmol; 1997; 20(8):592-8. PubMed ID: 9515117 [Abstract] [Full Text] [Related]
9. Pre-papillary vitreous opacities associated with Behçet's disease: a case series and review of the literature. Grotting LA, Davoudi S, Uchiyama E, Lobo AM, Papaliodis GN, Sobrin L. Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):2017-2021. PubMed ID: 28725920 [Abstract] [Full Text] [Related]
13. [Outcome of Behçet disease in ophthalmological milieu in Morocco]. Ouazzani B, Benchekroun N, el Aouni A, Hajji Z, Chaoui Z, Berraho-Hamani A. J Fr Ophtalmol; 1995 Nov; 18(2):124-7. PubMed ID: 7738304 [Abstract] [Full Text] [Related]
14. Intravitreal injections of triamcinolone acetonide for severe vitritis in patients with incomplete Behcet's disease. Kramer M, Ehrlich R, Snir M, Friling R, Mukamel M, Weinberger D, Axer-Siegel R. Am J Ophthalmol; 2004 Oct; 138(4):666-7. PubMed ID: 15488806 [Abstract] [Full Text] [Related]
15. [Ocular manifestations of Behçet's syndrome: 42 cases]. Daghfous MT, Ammar M, Kamoun M, Triki F. Tunis Med; 1980 Oct; 58(3):494-8. PubMed ID: 7456128 [No Abstract] [Full Text] [Related]
17. Ocular manifestations of Behcet's disease. A SE, Moses PD, George R. Indian Pediatr; 2005 Sep; 42(9):942-5. PubMed ID: 16208057 [Abstract] [Full Text] [Related]